Geneva, Nov. 2 -- International Clinical Trials Registry received information related to the study (ChiCTR2600135086) titled 'Impact of remimazolam tosylate administration for general anesthesia induction and maintenance on postoperative recovery outcomes: a multicenter, large-sample retrospective study' on Oct. 23.
Study Type: Observational study
Study Design:
Sequential
Primary Sponsor: Shandong Public Health Clinical Center
Condition:
Common adverse reactions during the PACU period (nausea and vomiting, upper airway obstruction, hypotension, hypoxemia, delayed awakening)
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-10-23
Target Sample Size: Remimazolam group:300;
Countries of Recruitment:...